The SCOP-induced cognitive deficit models in an in vivo study have been reported to reduce antioxidant enzyme activity and exhibit cholinergic dysfunction, like increased AChE and decreased ACh as in AD patients [25]. This evidence concerns the gene ACHE and Alzheimer disease.